This study is in progress, not accepting new patients
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
a study on Melanoma Skin Cancer/Melanoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information
- FDA Safety Alerts and Recalls
- BMS clinical trial educational resource
- Investigator Inquiry Form
- ID
- NCT01844505
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated